MENOPAUSE AND METABOLIC HEALTH: THE HIDDEN RISKS PRESENT IN GEORGIA
DOI:
https://doi.org/10.52340/jecm.2025.06.09Keywords:
Menopause, Metabolic Health, Insulin Resistance, Public Health, GeorgiaAbstract
Menopause represents a natural biological transition characterized by declining estrogen levels and profound metabolic changes. Estrogen deficiency contributes to insulin resistance, dyslipidemia, and visceral fat accumulation, increasing the risk of type 2 diabetes and cardiovascular disease. In Georgia, these risks often remain unrecognized due to the lack of targeted prevention and screening programs. This article discusses the physiological mechanisms underlying menopausal metabolic alterations, presents local epidemiological data, and outlines public-health strategies for early detection and prevention.
Downloads
References
World Health Organization. Menopause: Definition and Health Implications. Geneva: WHO, 2024.
The North American Menopause Society (NAMS). Hormone Therapy Position Statement. Menopause Journal, 2022.
The Lancet Diabetes & Endocrinology. Menopause as a Cardiometabolic Transition. 2023;10(5):321-330.
Endocrine Society. Hormones and Aging: Scientific Statement. J Clin Endocrinol Metab. 2023;108(3):540-552.
NCBI PMC. Metabolic Disorders in Menopause: Review. 2024.
Frontiers in Endocrinology. Oxidative Stress and Inflammation in Postmenopausal Women. 2023;14(103):212-220.
MDPI Nutrients. Lifestyle Interventions in Postmenopausal Metabolic Health. 2024;16(2):550-563.
The Lancet Public Health. Public Health Opportunities in Menopausal Health. 2023;8(9):e600-e608.
STEPS Survey Georgia. World Health Organization, 2016.
Dyslipidemia Study in Georgia, 2019. NCDC Georgia.
